Engaging Novel Cell Types, Protein Targets and Efficacy Biomarkers in the Treatment of Diabetic Nephropathy

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2014.00185
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

MicroRNAs in Diabetic Nephropathy: Functions, Biomarkers, and Therapeutic Targets

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2015English

Novel Biomarkers for Early Diagnosis and Progression of Diabetic Nephropathy

ARC Journal of Diabetes and Endocrinology
2015English

Thiamine in Diabetic Nephropathy: A Novel Treatment Modality?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2016English

T-Cell and B-Cell Signaling Biomarkers and Treatment Targets in Lupus

Current Opinion in Rheumatology
Rheumatology
2009English

Novel Mechanisms of Protein Synthesis in Diabetic Nephropathy—role of mRNA Translation

Reviews in Endocrine and Metabolic Disorders
EndocrinologyMetabolismDiabetes
2008English

Diabetic Nephropathy: Pathogenesis and Treatment

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1996English

Diabetic Nephropathy &Ndash; Complications and Treatment

International Journal of Nephrology and Renovascular Disease
Nephrology
2014English

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

Kidney International Reports
Nephrology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy